Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001964306-25-000006
Filing Date
2025-01-03
Accepted
2025-01-03 18:04:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2942
  Complete submission text file 0001964306-25-000006.txt   4384
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Subject) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40551 | Film No.: 25508305
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ACUMEN PHARMACEUTICALS, INC. 427 PARK STREET CHARLOTTESVILLE VA 22902
Business Address
Siemers Eric (Reporting) CIK: 0001866239 (see all company filings)

Type: 144